Mechanistic role of pyroptosis in tumor microenvironment and tumor immunotherapy

Rukset Attar1, Muhammad Zahid Qureshi2, Uteuliyev Yerzhan Sabitaliyevich3

  • 1Department of Obstetrics and Gynecology, Yeditepe University Hospital, 34755 Istanbul, Turkey. ruksetattar@hotmail.com.

Insights

Pyroptosis, a programmed cell death pathway, involves gasdermin pore formation and plays a key role in immunity and cancer. Understanding its signaling pathways can help target cancer inhibition and metastasis.

Area of Science:

  • Cell Biology
  • Immunology
  • Oncology

Background:

  • Programmed cell death (PCD) pathways are crucial for development and disease.
  • Pyroptosis is a pro-inflammatory cell death form regulated by gasdermin pore formation.
  • Pyroptosis is critical in innate immunity and influenced by inflammasome-dependent and independent cascades.

Purpose of the Study:

  • To review the regulation of pyroptosis by signaling pathways.
  • To analyze pyroptosis's role in cancer inhibition and metastasis.

Main Methods:

  • Comprehensive literature review of signaling pathways regulating pyroptosis.
  • Analysis of pyroptosis mechanisms in cancer biology.

Main Results:

  • Pyroptosis, characterized by gasdermin-NT pore formation, is a key inflammatory cell death.
  • Signaling pathways intricately regulate pyroptosis in the context of cancer.
  • Pyroptosis influences cancer inhibition and the metastatic spread of cancer cells.

Conclusions:

  • Understanding the interplay between signaling pathways and pyroptosis is vital.
  • This knowledge can optimize therapeutic strategies targeting cancer progression.
  • Further research into pyroptosis mechanisms holds promise for cancer treatment.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
903
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K